Trial Details
COMPLETEDBasic Information
| Clinical ID | c1246 |
|---|---|
| Identifier | NCT03861143 |
| Trial Title | Efficacy and Safety of Oral BT-11 in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: BT-11 (440 mg)|DRUG: BT-11 (880 mg)|DRUG: Placebo |
Participant Information
| Sponsor | NImmune Biopharma |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-08-14 |
|---|---|
| Primary Completion Date | 2020-12-10 |
| Completion Date | 2021-06-17 |